This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,238.12 firm-fixed-price delivery order contract is for the supply of Letrozole 2.5 mg tablets, a medication used in the treatment of breast cancer. The contract has an ultimate completion date of October 30, 2024 and does not include any set-aside designations, indicating open competition. AmerisourceBergen holds...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $1,064.85 firm fixed-price contract is for the supply of 4,565,708,495 units of Letrozole 2.5 mg Tablets, a medication used to treat certain types of breast cancer. The contract has an ultimate completion date of September 9, 2024. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,660.08, is for the delivery of 4,566,931,331 units of Letrozole 2.5 mg tablets in 90-count packages. The contract has a period of performance through January 15, 2025 and is a Firm Fixed Price contract. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $1,883.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Letrozole 2.5 mg tablets, a medication used to treat breast cancer, to support federal healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,406.44, is for the delivery of Letrozole 2.5 mg tablets, a prescription medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,219.02, is for the delivery of the generic drug Letrozole 2.5 mg tablets. The contract is a firm fixed-price delivery order, with a completion date of January 14, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $2,585.46, is for letrozole 2.5 mg tablets and has a completion date of February 18, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,742.21 for the supply of Letrozole 2.5 mg tablets. The contract has an ultimate completion date of January 9, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,661.95, is for the delivery of LETROZOLE 2.5 MG TABLET 90S, a generic medication used to treat breast cancer. The contract has a firm fixed price pricing type and a completion date of November 4, 2024. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,045.56 firm fixed-price delivery order is for the supply of Letrozole 2.5 mg tablets, with an ultimate completion date of November 5, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...